Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' AZNAR J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 161 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Vaya, A; Martinez, M; Fernandez, A; Ripoli, F; Moscardo, F; Mira, Y; Aznar, J
      The effect of acenocoumarol on hemorheological parameters

      CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
    2. Mira, Y; Todoli, J; Alonso, R; Mico, ML; Vaya, A; Ferrando, F; Estelles, A; Villa, P; Aznar, J
      Factor V Leiden and prothrombin G20210A in relation to arterial and/or vein rethrombosis: Two cases

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    3. Vaya, A; Resureccion, T; Ricart, JM; Ortuno, C; Ripoll, F; Mira, Y; Aznar, J
      Spontaneous cervical epidural hematoma associated with oral anticoagulant therapy

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    4. Vaya, A; Todoli, J; Ricart, J; Estelles, A; Mira, Y; Villa, P; Calabuig, JR; Aznar, J
      Upper extremity deep vein thrombosis in a young patient double heterozygous for factor V Leiden and prothrombin G20210A mutation

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    5. Lozano, JV; Llisterri, JL; Aznar, J; Redon, J
      Losartan reduces microalbuminuria in hypertensive microalbuminuric type 2 diabetics

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    6. Vila, V; Martinez-Sales, V; Reganon, E; Peris, E; Perez, F; Ruano, M; Aznar, J
      Effects of unfractionated and low molecular weight heparins on plasma levels of hemostatic factors in patients with acute coronary syndromes

      HAEMATOLOGICA
    7. Villa, P; Iborra, J; Serra, J; Gilsanz, A; Casana, P; Aznar, JA; Aznar, J
      Evaluation of an automated method for the quantification of von Willebrandfactor antigen. Its application in the study of vascular dysfunction

      HAEMATOLOGICA
    8. Falco, C; Tormo, G; Estelles, A; Espana, F; Tormo, E; Gilabert, J; Velasco, JA; Aznar, J
      Fibrinolysis and lipoprotein(a) in women with coronary artery disease. Influence of hormone replacement therapy

      HAEMATOLOGICA
    9. Serradell, M; Diaz-Ricart, M; Cases, A; Zurbano, MJ; Aznar-Salatti, J; Lopez-Pedre, J; Ordinas, A; Escolar, G
      Uremic medium disturbs the hemostatic balance of cultured human endothelial cells

      THROMBOSIS AND HAEMOSTASIS
    10. Estelles, A; Dalmou, J; Falco, C; Berbel, O; Castello, R; Espana, F; Aznar, J
      Plasma PAI-1 levels in obese children - Effect of weight loss and influence of PAI-1 promoter 4G/5G genotype

      THROMBOSIS AND HAEMOSTASIS
    11. Fernandez, MA; Andreu, R; Fortea, JM; Aznar, J
      The blue toe syndrome during oral anticoagulant therapy with acenocoumarol

      THROMBOSIS AND HAEMOSTASIS
    12. Vaya, A; Garcia, M; Mira, Y; Ferrando, F; Villa, P; Estelles, A; Aznar, J
      Homozygous 20210G/A prothrombin gene mutation associated with bilateral iliac vein thrombosis: A case report

      THROMBOSIS RESEARCH
    13. Aznar, J; Cerrada, E; Hursthouse, MB; Laguna, M; Pozo, C; Romero, MP
      Heteronuclear tin(IV)-silver(I) complexes with phosphinothiolate ligands. X-ray structure of [AgSn(mu-SC6H4PPh2)(2)Me-2(PPh2Me)]CF3SO3 center dot CH2Cl2

      JOURNAL OF ORGANOMETALLIC CHEMISTRY
    14. Martinez, M; Vaya, A; Lopez-Camacho, C; Coll-Sangrona, E; Mira, Y; Aznar, J
      High and low molecular weight heparins do not modify red blood cell aggregability in vitro

      CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
    15. Mira, Y; Aznar, J; Estelles, A
      Congenital and acquired thrombotic risk factors in women using oral contraceptives: Clinical aspects

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    16. Mira, Y; del Castillo, GG; Estelles, A; Villa, P; Vaya, A; Ortuno, C; Aznar, J
      Portal vein thrombosis associated to prothrombin G20210A mutation and protein C deficiency

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    17. Vaya, A; Trenor, R; Molla, S; Estelles, A; Mira, Y; Villa, P; Aznar, J
      Acute myocardial infarction associated with the prothrombin G20210A mutation

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    18. Villa, P; Ferrando, F; Serra, J; Faus, H; Mira, Y; Vaya, A; Aznar, J
      Quantification of D-dimer using a new fully automated assay: its application for the diagnosis of deep vein thrombosis

      HAEMATOLOGICA
    19. Vaya, A; Forner, MJ; Estelles, A; Villa, P; Mira, Y; Ferrando, F; Fuster, MJG; Oliver, V; Aznar, J
      Intracardiac thrombosis in a case of Behcet's disease associated with the prothrombin 20210G-A mutation

      HAEMATOLOGICA
    20. Diaz-Ricart, M; Estebanell, E; Lozano, M; Aznar-Salatti, J; White, JG; Ordinas, A; Escolar, G
      Thrombin facilitates primary platelet adhesion onto vascular surfaces in the absence of plasma adhesive proteins: studies under flow conditions

      HAEMATOLOGICA
    21. Aznar, J; Vaya, A; Estelles, A; Mira, Y; Segui, R; Villa, P
      Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives

      HAEMATOLOGICA
    22. Estelles, A; Villa, P; Mira, Y; Vaya, A; Segui, R; Aznar, J
      Factor V Leiden in absence of activated protein C resistance after orthotopic liver transplantation in a patient without thrombosis but with familialthrombophilia

      HAEMATOLOGICA
    23. Martinez, M; Espana, F; Royo, M; Vera, CD; Estelles, A; Jimenez-Cruz, JF; Medina, P; Aznar, J
      Prostate-specific antigen complexed to alpha(1)-antichymotrypsin in the early detection of prostate cancer

      EUROPEAN UROLOGY
    24. Aros, F; Boraita, A; Alegria, E; Alonso, AM; Bardaji, A; Lamiel, R; Luengo, E; Rabadan, M; Alijarde, M; Aznar, J; Bano, A; Cabanero, M; Calderon, C; Camprubi, M; Candell, J; Crespo, M; de la Morena, G; Fernandez, A; Ferrero, JA; Gayan, R; Bolao, IG; Hernandez, M; Maceira, A; Marin, E; de Lara, AM; Placer, L; San Roman, JAS; Serratosa, L; Sosa, V; Subirana, MT; Wilke, M
      Guidelines of the Spanish Society of Cardiology for clinical practice in exercise testing

      REVISTA ESPANOLA DE CARDIOLOGIA
    25. Torres, MJ; Criado, A; Palomares, JC; Aznar, J
      Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis

      JOURNAL OF CLINICAL MICROBIOLOGY
    26. Mendez-Sanchez, N; Baptista-Gonzalez, H; Sanchez-Gomez, H; Bordes-Aznar, J; Uribe, M
      Comment on the article about hepatitis B and C prevalence in donor blood -The authors reply

      SALUD PUBLICA DE MEXICO
    27. Santos, MT; Moscardo, A; Valles, J; Martinez, M; Pinon, M; Aznar, J; Broekman, MJ; Marcus, AJ
      Participation of tyrosine phosphorylation in cytoskeletal reorganization, alpha(IIb)beta(3) integrin receptor activation, and aspirin-insensitive mechanisms of thrombin-stimulated human platelets

      CIRCULATION
    28. Segui, R; Estelles, A; Mira, Y; Espana, F; Villa, P; Falco, C; Vaya, A; Grancha, S; Ferrando, F; Aznar, J
      PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects

      BRITISH JOURNAL OF HAEMATOLOGY
    29. Garcia-Aguado, R; Gil, F; Barcia, JA; Aznar, J; Hostalet, F; Barbera, T; Grau, F
      Prophylactic percutaneous sealing of lumbar postdural puncture hole with fibrin glue to prevent cerebrospinal fluid leakage in swine

      ANESTHESIA AND ANALGESIA
    30. Labios, M; Martinez, M; Vaya, A; Gabriel, F; Guiral, V; Aznar, J
      Effect of a modified fibrate (Biniwas Retard) on hemorheological alterations in hyperlipemic patients

      CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
    31. Martinez, M; Vaya, A; Alvarino, J; Barbera, JL; Ramos, D; Lopez, A; Aznar, J
      Hemorheological alterations in patients with chronic renal failure. Effectof hemodialysis

      CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
    32. Vaya, A; Martinez, M; Ballesta, A; Marti, R; Ortuno, C; Aznar, J
      Thrombomodulin levels in asymptomatic familial hypercholesterolemia

      CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
    33. Vaya, A; Lopez, JM; Mira, Y; Ricart, JM; Villa, P; Espana-Gregori, E; Estelles, A; Aznar, J
      Central retinal vein thrombosis associated with prothrombin 20210G/A gene variant

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    34. Aznar, J; Villa, P; Espana, F
      Functional diagnosis of activated protein C resistance in patients with antiphospholipid antibodies

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    35. Fernandez, MA; Regadera, A; Aznar, J
      Acenocoumarol and 6-mercaptopurine: an important drug interaction

      HAEMATOLOGICA
    36. Espana, F; Villa, P; Mira, Y; Grancha, S; Royo, M; Estelles, A; Vaya, A; Aznar, J
      Factor V Leiden and antibodies against phospholipids and protein S in a young woman with recurrent thromboses and abortion

      HAEMATOLOGICA
    37. Reganon, E; Vila, V; Ferrando, F; Martinez-Sales, V; Fayos, L; Ruano, M; Aznar, J
      Elevated high molecular weight fibrinogen in plasma is predictive of coronary ischemic events after acute myocardial infarction

      THROMBOSIS AND HAEMOSTASIS
    38. Villa, P; Aznar, J; Vaya, A; Espana, F; Ferrando, F; Mira, Y; Estelles, A
      Hereditary homozygous heparin cofactor II deficiency and the risk of developing venous thrombosis

      THROMBOSIS AND HAEMOSTASIS
    39. Vaya, A; Martinez, M; Ortuno, C; Lopez, JM; Aznar, J
      Intraindividual variability in plasma viscosity in relation to their utility as a cardiovascular risk factor

      THROMBOSIS AND HAEMOSTASIS
    40. Grancha, S; Estelles, A; Tormo, G; Falco, C; Gilabert, J; Espana, F; Cano, A; Segui, R; Aznar, J
      Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary arterydisease - Influence of hormone replacement therapy

      THROMBOSIS AND HAEMOSTASIS
    41. Estelles, A; Cano, A; Falco, C; Espana, F; Gilabert, J; Grancha, S; Aznar, J
      Lipoprotein(a) levels and isoforms and fibrinolytic activity in postmenopause - Influence of hormone replacement therapy

      THROMBOSIS AND HAEMOSTASIS
    42. Galan, AM; Reverter, JC; Bozzo, J; Hernandez, MR; Escolar, G; Aznar-Salatti, J
      Assessment of potential thrombogenicity of coagulation factor IX concentrates in an in vitro model of human thrombogenesis

      THROMBOSIS RESEARCH
    43. Mendez-Sanchez, N; Baptista-Gonzalez, H; Sanchez-Gomez, RH; Bordes-Aznar, J; Uribe-Esquivel, M
      Prevalence of type C and B hepatitis in blood donors at a third level hospital of Mexico City

      SALUD PUBLICA DE MEXICO
    44. Espana, F; Royo, M; Martinez, M; Enguidanos, MJ; Vera, CD; Estelles, A; Aznar, J; Jimenez-Cruz, JF; Heeb, MJ
      Free and complexed prostate specific antigen in the differentiation of benign prostatic hyperplasia and prostate cancer: Studies in serum and plasma samples - Reply

      JOURNAL OF UROLOGY
    45. VAYA A; MARTINEZ M; DALMAU J; MARTI R; BALLESTA A; AZNAR J
      PLASMA THROMBOMODULIN IS NOT INCREASED IN FAMILIAL HYPERCHOLESTEROLEMIC CHILDREN WITH RHEOLOGICAL ALTERATIONS

      Clinical hemorheology and microcirculation
    46. VAYA A; MARTINEZ M; GUILLEN M; DALMAU J; AZNAR J
      ERYTHROCYTE DEFORMABILITY IN YOUNG FAMILIAL HYPERCHOLESTEROLEMICS

      Clinical hemorheology and microcirculation
    47. MARTINEZ M; VAYA A; SERVER R; GILSANZ A; AZNAR J
      ALTERATIONS IN ERYTHROCYTE AGGREGABILITY IN DIABETICS - THE INFLUENCEOF PLASMATIC FIBRINOGEN AND PHOSPHOLIPIDS OF THE RED-BLOOD-CELL MEMBRANE

      Clinical hemorheology and microcirculation
    48. MARTINEZ M; VAYA A; GIL L; MARTI R; DALMAU J; AZNAR J
      THE CHOLESTEROL PHOSPHOLIPID RATIO OF THE ERYTHROCYTE-MEMBRANE IN CHILDREN WITH FAMILIAL HYPERCHOLESTEROLEMIA - ITS RELATIONSHIP WITH PLASMA-LIPIDS AND RED-BLOOD-CELL AGGREGABILITY/

      Clinical hemorheology and microcirculation
    49. Mira, Y; Vaya, A; Martinez, M; Villa, P; Santaolaria, ML; Ferrando, F; Aznar, J
      Hemorheological alterations and hypercoagulable state in deep vein thrombosis

      CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
    50. Martinez, M; Vaya, A; Server, R; Santaolaria, M; Aznar, J
      Erythrocyte elongation index measured on a Rheodyn SSD laser diffractometer. Influence of the hematocrit

      CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
    51. Vaya, A; Martinez, M; Dalmau, J; Aznar, J
      Hemorheological changes in children with polygenic hypercholesterolemia

      CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
    52. ESPANA F; ESTELLES A; AZNAR J
      EFFECTS OF APROTININ ON COAGULATION AND FIBRINOLYSIS ENZYMES

      FIBRINOLYSIS & PROTEOLYSIS
    53. GRANCHA S; ESTELLES A; FALCO C; CHIRIVELLA N; ESPANA F; AZNAR J
      DETAILED LOCALIZATION OF TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR MESSENGER-RNA EXPRESSION AND ANTIGEN IN ATHEROSCLEROTIC PLAQUE ON HUMAN CORONARY-ARTERY

      FIBRINOLYSIS & PROTEOLYSIS
    54. ESPANA F; MARTINEZ M; ROYO M; VERA CD; ESTELLES A; AZNAR J; JIMENEZCRUZ JF
      LONGITUDINAL EVALUATION OF THE COMPLEXED-TO-TOTAL PROSTATE-SPECIFIC ANTIGEN RATIO IN MEN WITH PROSTATE DISEASE - EFFECT OF TREATMENT

      European journal of cancer
    55. FERNANDEZ MA; VILLA P; ESPANA F; AZNAR J; DEARELLANO AR; CEBOLLA R
      MARKERS OF COAGULATION AND PLATELET ACTIVATION DURING PERCUTANEOUS MITRAL VALVULOPLASTY

      Blood coagulation & fibrinolysis
    56. CREMADES MJ; MENENDEZ R; PASTOR A; LLOPIS R; AZNAR J
      DIAGNOSTIC-VALUE OF CYTOKERATIN FRAGMENT-19 (CYFRA 21-1) IN BRONCHOALVEOLAR LAVAGE FLUID IN LUNG-CANCER

      Respiratory medicine
    57. MAZUECOS J; AZNAR J; RODRIGUEZPICHARDO A; MARMESAT F; BOROBIO MV; PEREA EJ; CAMACHO F
      ANAEROBIC-BACTERIA IN MEN WITH URETHRITIS

      JEADV. Journal of the European Academy of Dermatology and Venereology
    58. Escolar, G; Carretero, M; Magallon, M; Quintana, M; Arnau, C; Castillo, R; Aznar-Salatti, J
      von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease

      HAEMATOLOGICA
    59. FERNANDEZ MA; BALLESTEROS S; AZNAR J
      ORAL ANTICOAGULANTS AND INSECTICIDES

      Thrombosis and haemostasis
    60. FALCO C; ESTELLES A; DALMAU J; ESPANA F; AZNAR J
      INFLUENCE OF LIPOPROTEIN (A) LEVELS AND ISOFORMS ON FIBRINOLYTIC-ACTIVITY - STUDY IN FAMILIES WITH HIGH LIPOPROTEIN (A) LEVELS

      Thrombosis and haemostasis
    61. ESTELLES A; GILABERT J; GRANCHA S; YAMAMOTO K; THINNES T; ESPANA F; AZNAR J; LOSKUTOFF DJ
      ABNORMAL EXPRESSION OF TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR AND TISSUE FACTOR IN SEVERE PREECLAMPSIA

      Thrombosis and haemostasis
    62. VAYA A; MARTINEZ M; AZNAR J
      THE EFFECT OF AGE AND MENOPAUSE ON ERYTHROCYTE AGGREGATION

      Thrombosis and haemostasis
    63. Martinez-Sales, V; Vila, V; Reganon, E; Goberna, MA; Ferrando, F; Palencia, MA; Aznar, J
      Elevated thrombotic activity after myocardial infarction: A 2-year follow-up study

      HAEMOSTASIS
    64. Reganon, E; Ferrando, F; Vila, V; Villa, P; Martinez-Sales, V; Fayos, L; Ruano, M; Aznar, J
      Increase in thrombin generation after coronary thrombolysis with rt-PA or streptokinase with simultaneous heparin versus heparin alone

      HAEMOSTASIS
    65. DIAGO M; BELTRA M; BORDERIA R; AZNAR J; GARCIA V
      OUTBREAK OF HEPATITIS-C IN VALENCIA - AN UNPRECEDENTED TRANSMISSION BY A PROBABLE MEDICAL MALPRACTICE

      Hepatology
    66. ESPANA F; ROYO M; MARTINEZ M; ENGUIDANOS MJ; VERA CD; ESTELLES A; AZNAR J; JIMENEZCRUZ JF; HEEB MJ
      FREE AND COMPLEXED PROSTATE-SPECIFIC ANTIGEN IN THE DIFFERENTIATION OF BENIGN PROSTATIC HYPERPLASIA AND PROSTATE-CANCER - STUDIES IN SERUM AND PLASMA SAMPLES

      The Journal of urology
    67. GARCIAHERNANDEZ MJ; TORRES MJ; PALOMARES JC; RODRIGUEZPICHARDO A; AZNAR J; CAMACHO F
      NO EVIDENCE OF CYTOMEGALOVIRUS DNA IN ALOPECIA-AREATA

      Journal of investigative dermatology
    68. VALLES J; SANTOS MT; AZNAR J; OSA A; LAGO A; COSIN J; SANCHEZ E; BROEKMAN MJ; MARCUS AJ
      ERYTHROCYTE PROMOTION OF PLATELET REACTIVITY DECREASES THE EFFECTIVENESS OF ASPIRIN AS AN ANTITHROMBOTIC THERAPEUTIC MODALITY - RESPONSE

      Circulation
    69. VALLES J; SANTOS MT; AZNAR J; OSA A; LAGO A; COSIN J; SANCHEZ E; BROEKMAN MJ; MARCUS AJ
      ERYTHROCYTE PROMOTION OF PLATELET REACTIVITY DECREASES THE EFFECTIVENESS OF ASPIRIN AS AN ANTITHROMBOTIC THERAPEUTIC MODALITY - THE EFFECT OF LOW-DOSE ASPIRIN IS LESS-THAN OPTIMAL IN PATIENTS WITH VASCULAR-DISEASE DUE TO PROTHROMBOTIC EFFECTS OF ERYTHROCYTES ON PLATELET REACTIVITY

      Circulation
    70. SANTOS MT; VALLES J; AZNAR J; MARCUS AJ; BROEKMAN MJ
      DAILY 50 MG OR 500 ASPIRIN DOES NOT AFFECT THE COOPERATION OF THE OF ARACHIDONIC-ACID AND ADP ON PLATELET-AGGREGATION - RESPONSE

      Circulation
    71. VAZQUEZ A; VILLALBA F; ARTIGUES E; GARCIACORET MJ; AZNAR J; MONTALVA E
      DIETARY FIBER - THE EFFECTS ON EXPERIMENTAL COLONIC ANASTOMOSES

      British Journal of Surgery
    72. AZNAR J
      DIAGNOSIS OF ACTIVATED PROTEIN-C RESISTANCE IN RETINAL VEIN OCCLUSION

      British journal of ophthalmology
    73. MARTINEZ M; VAYA A; LABIOS M; GABRIEL F; GUIRAL V; AZNAR J
      THE EFFECT OF LONG-TERM TREATMENT WITH HYPOTENSIVE DRUGS ON BLOOD-VISCOSITY AND ERYTHROCYTE DEFORMABILITY IN PATIENTS WITH ESSENTIAL ARTERIAL-HYPERTENSION

      Clinical hemorheology and microcirculation
    74. RODRIGUEZBANO J; MUNIAIN MA; AZNAR J; PEREZCANO R; CORRAL JL
      SYSTEMIC PARADOXICAL RESPONSE TO ANTITUBERCULOUS DRUGS - RESOLUTION WITH CORTICOSTEROID-THERAPY

      Clinical infectious diseases
    75. PASTOR A; MENENDEZ R; CREMADES MJ; PASTOR V; LLOPIS R; AZNAR J
      DIAGNOSTIC-VALUE OF SCC, CEA AND CYFRA-21.1 IN LUNG-CANCER - A BAYESIAN-ANALYSIS

      The European respiratory journal
    76. MARTINEZSALES V; VILA V; REGANON E; AZNAR J; FERRANDO F; PALENCIA MA
      PLATELET-FUNCTION OF PATIENTS TREATED WITH ASA FOR 6 MONTHS AFTER AMI

      Thrombosis and haemostasis
    77. MARTINEZ M; VAYA A; LABIOS M; GUIRAL V; GABRIEL F; AZNAR J
      EFFECTS OF TREATMENT WITH BINIFIBRATE ON THE HEMORHEOLOGICAL ALTERATIONS IN HYPERLIPIDEMIC PATIENTS

      Thrombosis and haemostasis
    78. FALCO C; ESTELLES A; DALMAU J; ESPANA F; AZNAR J
      INFLUENCE OF THE LEVELS AND ISOFORMS OF LIPOPROTEIN (A) [LP(A)] ON FIBRINOLYTIC-ACTIVITY - STUDY IN FAMILIES WITH HIGH LP(A) LEVELS

      Thrombosis and haemostasis
    79. MOSCARDO A; SANTOS MT; VALLES J; AZNAR J
      PROTEIN-TYROSINE KINASE MODULATES HUMAN PLATELET TXA(2) SYNTHESIS ANDCYCLOOXYGENASE-INDEPENDENT PLATELET ACTIVATION

      Thrombosis and haemostasis
    80. VAYA A; CID A; CASANOVA B; MIRA Y; VILLA P; AZNAR J
      CEREBRAL INFARCT-RELATED TO COCAINE ABUSE

      Thrombosis and haemostasis
    81. AZNAR J; VILLA P; ESPANA F; ESTELLES A; GRANCHA S; FALCO C
      PHENOTYPIC RESISTANCE TO ACTIVATED PROTEIN-C IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES

      Thrombosis and haemostasis
    82. GRANCHA S; ESTELLES A; GILABERT J; CHIRIVELLA M; ESPANA F; AZNAR J
      ALTERED EXPRESSION OF PAI-2 MESSENGER-RNA IN PLACENTAS FROM PREGNANCIES COMPLICATED WITH INTRAUTERINE FETAL GROWTH-RETARDATION (IUGR)

      Thrombosis and haemostasis
    83. ROYO M; ESPANA F; FERNANDEZ P; MARCO P; ESTELLES A; AZNAR J
      REDUCED LEVELS OF CIRCULATING ACTIVATED PROTEIN-C IN PATIENTS WITH MYOCARDIAL-INFARCTION

      Thrombosis and haemostasis
    84. VAYA A; MARTINEZ M; DALMAU J; AZNAR J
      ERYTHROCYTE AGGREGATION AND PLASMA VISCOSITY IN CHILDREN WITH POLYGENIC HYPERCHOLESTEROLEMIA

      Thrombosis and haemostasis
    85. VALLES J; SANTOS MT; AZNAR J; LAGO A; OSO A; COSIN J; MOSCARDO A
      ERYTHROCYTE PROMOTION OF PLATELET REACTIVITY REDUCES THE EFFECTIVENESS OF ASPIRIN IN PATIENTS WITH VASCULAR-DISEASE

      Thrombosis and haemostasis
    86. ESTELLES A; TORMO G; GILABERT J; FALCO C; ESPANA F; RODRIGUEZ J; TORMO V; AZNAR J
      FIBRINOLYSIS AND LIPOPROTEIN (A) [LP(A)] IN CORONARY-ARTERY DISEASE (CAD) - INFLUENCE OF POSTMENOPAUSAL STATUS AND HORMONE REPLACEMENT THERAPY (HRT)

      Thrombosis and haemostasis
    87. REGANON E; VILA V; MARTINEZSALES V; AZNAR J; FERRANDO F; PALENCIA MA
      CHANGES IN HYPERCOAGULABLE STATE OF AMI PATIENTS TREATED WITH ASA FOR6 MONTHS AFTER MYOCARDIAL-INFARCTION

      Thrombosis and haemostasis
    88. FERNANDEZ MA; RIPOLL F; VILLA P; AZNAR J
      A PORTABLE MONITOR FOR THE PROTHROMBIN TIME DETERMINATION - AN ALTERNATIVE TO CONTROL THE ORAL ANTICOAGULANT-THERAPY

      Thrombosis and haemostasis
    89. ESPANA F; MARTINEZ M; ROYO M; VERA CD; ESTELLES A; AZNAR J; JIMENEZCRUZ JF
      REFERENCE RANGES FOR THE CONCENTRATIONS OF TOTAL AND COMPLEXED PLASMAPROSTATE-SPECIFIC ANTIGEN AND THEIR RATIO IN PATIENTS WITH BENIGN PROSTATE HYPERPLASIA

      European urology
    90. SAFI H; AZNAR J; PALOMARES JC
      MOLECULAR EPIDEMIOLOGY OF MYCOBACTERIUM-TUBERCULOSIS STRAINS ISOLATEDDURING A 3-YEAR PERIOD (1993 TO 1995) IN SEVILLE, SPAIN

      Journal of clinical microbiology
    91. VILA V; MARTINETSALES V; REGANON E; AZNAR J
      FIBRINOPEPTIDE A RELEASE FROM INTRAPLATELET FIBRINOGEN IS RELATED TO THROMBIN PLATELET ACTIVATION

      Thrombosis research
    92. AZNAR J; VILLA P; ESPANA F; ESTELLES A; GRANCHA S; FALCO C
      ACTIVATED PROTEIN-C RESISTANCE PHENOTYPE IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES

      The Journal of laboratory and clinical medicine
    93. VALLES J; SANTOS MT; AZNAR J; VELERT M; BARBERA G; CARMENA R
      MODULATORY EFFECT OF ERYTHROCYTES ON THE PLATELET REACTIVITY TO COLLAGEN IN IDDM PATIENTS

      Diabetes
    94. SANTOS MT; VALLES J; AZNAR J; MARCUS AJ; BROEKMAN MJ; SAFIER LB
      PROTHROMBOTIC EFFECTS OF ERYTHROCYTES ON PLATELET REACTIVITY - REDUCTION BY ASPIRIN

      Circulation
    95. VILA V; MARTINEZSALES V; REGANON E; AZNAR J
      THE EFFECT OF THROMBIN ON THE DYNAMIC EXCHANGE BETWEEN INTRAPLATELET AND EXTRAPLATELET FIBRINOGEN

      British Journal of Haematology
    96. MIRA Y; MENDIZABAL S; VAYA A; SANCHIS N; VILLA P; AZNAR J
      SINUS VENOUS THROMBOSIS ASSOCIATED WITH A NEPHROTIC SYNDROME IN AN 8-YEAR-OLD CHILD

      Clinical and applied thrombosis/hemostasis
    97. REGANON E; VILA V; MARTINEZSALES V; AZNAR J
      LACK OF EFFECT OF THROMBIN ON FIBRIN(OGEN)-ENDOTHELIAL CELL-INTERACTION

      Cytotechnology
    98. AZNAR J; ESPANA F; ESTELLES A; ROYO M
      HEPARIN STIMULATION OF THE INHIBITION OF ACTIVATED PROTEIN-C AND OTHER ENZYMES BY HUMAN PROTEIN-C INHIBITOR - INFLUENCE OF THE MOLECULAR-WEIGHT OF HEPARIN AND IONIC-STRENGTH

      Thrombosis and haemostasis
    99. GRANCHA S; ESTELLES A; GILABERT J; CHIRIVELLA M; ESPANA F; AZNAR J
      DECREASED EXPRESSION OF PAI-2 MESSENGER-RNA AND PROTEIN IN PREGNANCIES COMPLICATED WITH INTRAUTERINE PETAL GROWTH-RETARDATION

      Thrombosis and haemostasis
    100. ESPANA F; ZUAZU I; VICENTE V; ESTELLES A; MARCO P; AZNAR J
      QUANTIFICATION OF CIRCULATING ACTIVATED PROTEIN-C IN HUMAN PLASMA BY IMMUNOASSAYS - ENZYME LEVELS ARE PROPORTIONAL TO TOTAL PROTEIN-C LEVELS

      Thrombosis and haemostasis


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 03:31:33